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http://dx.doi.org/10.1016/j.ccr.2013.08.016Wewere very interested to read in Cancer
Cell the recent paper by Schumacher
et al., ‘‘Platelet-Derived Nucleotides Pro-
mote Tumor Cell Transendothelial Migra-
tion and Metastasis via P2Y2 Receptor’’
(Schumacher et al., 2013). In this paper,
the authors show the importance of
platelet secretion in promoting tumor
metastasis and convincingly demonstrate
an important role for ATP from platelet
dense granules acting on endothelial
P2Y2. Part of the evidence for this
depends on Munc13-4-deficient mice
(Unc13dJinx), whose platelets cannot
secrete their dense granules. However,
Schumacher et al. also report that there
was no difference in secretion of platelet
a-granules or in integrin activation (Fig-
ures 2A–2D, S2C, and S2D in Schu-
macher et al., 2013). These findings are
in contrast to published findings from
our lab and others (Ren et al., 2010; Sav-
age et al., 2013; Stegner et al., 2013).
Unc13dJinx platelets show reduced ag-
gregation, integrin aIIbb3 activation, and
thrombus formation in vitro and in vivo
(Ren et al., 2010; Savage et al., 2013). In-
tegrin activation and subsequent plateletaggregation and thrombus formation are
dependent on ADP secretion from platelet
dense granules and stimulation of platelet
P2Y12. The aggregation defects we have
seen in Unc13dJinx mice are therefore
perhaps not surprising since the platelets
of these mice cannot secrete their dense
granules. Ren et al. also showed that
thrombin-stimulated a-granule secretion
was reduced by approximately 70% in
Unc13dJinx platelets compared to wild-
type controls. Stegner et al. (2013) stated
that they saw a similar effect, and we
also observe substantially reduced
a-granule secretion in Unc13dJinx plate-
lets (data not shown). We have also
found that platelet a-granule secretion is
also partly regulated by autocrine ADP
secretion from dense granules, acting
through P2Y12. This partly accounts for
the defect we see in a-granule secretion
in Unc13dJinx platelets.
Platelet aggregation has been sug-
gested to promote tumor metastasis,
and platelet a-granules may also promote
tumor metastasis since they are a source
of a wide range of growth factors and
cytokines. For example, as reported inCancer Cell 24, Sanother recent Cancer Cell paper,
platelet-derived TGF-b plays a key role
in tumor metastasis (Labelle et al., 2011).
We suggest therefore that, in addition to
activation of endothelial P2Y2, another
way in which platelet-released nucleo-
tides might enhance tumor metastasis is
through autocrine activation of platelet
P2Y12 and enhancement of aggregation
and a-granule secretion.REFERENCES
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